Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

NCT00333684 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus
Facial Lipoatrophy

Interventions

DEVICE: BIO-ALCAMID SOFT TISSUE ENDOPROSTHESIS

Sponsor

Canadian Immunodeficiency Research Collaborative

Collaborators

[object Object]